Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+12.77%
-0.49%
-1.84%
+1.06%
CELH
Celsius Holdings Inc
$46.39
Chart
$35.24 (+31.64%)
$34.9 (+32.92%)
$34.9 (+32.92%)
$57.22 (-18.93%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+12.77%
-0.49%
-1.84%
+1.06%
CELH
Celsius Holdings Inc
Current Price
$46.39
Strong Buy
Login to view Celsius Holdings Inc (CELH) recommendation from the last 90 days from financial news and social media.
Chart
$35.24 (+31.64%)
$34.9 (+32.92%)
$34.9 (+32.92%)
$57.22 (-18.93%)
CELH Latest Analysis
Think Celsius Holdings Stock Is Expensive? This Chart Might Change Your Mind. Has Celsius Holdings (NASDAQ: CELH) become an expensive stock? Investors who dont examine the stock closely might believe so. Its price-to-earnings (P/E) ratio now exceeds 143 a dramatic surge from last fall when it fell to just above 30.
Fri Jun 27, 2025
Celsius Holdings (CELH) Stock Surges 22% In A Month: Whats Driving the Rally?. Shares of ) are soaring on Tuesday up 5.9% at $45.37 and capping a remarkable 22% gain over the past month. The rally comes amid recent ish commentary from J.P. Morgan which highlighted a significant acceleration in the United States energy drink market.reported that United States energy drink sales jumped 18% in May a sharp increase from 14% in April and the category’.s strongest growth rate since November 2023.
Tue Jun 24, 2025
Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388 a Non-Vaccine Preventative of Seasonal Influenza. The study met its primary and all secondary efficacy endpoints for all dose groupsSingle doses of 450mg 300mg and 150mg of CD388 conferred 76% 61% and 58% protection respectively from symptomatic influenza over 24 weeks compared to placebo CD388 was well-tolerated with no safety signals observedEnd of Phase 2 meeting request has been submitted
Mon Jun 23, 2025
Analyst Says Energy Drink Momentum Builds In May Celsius Outperforms. strongest growth rate since November 2023.The acceleration stemmed from gains in both buy rate which rose 88 basis points to 10% year-over-year and household penetration which climbed 113 basis points to 3.25% year-over-year.): Teixeira said the data also bode well for Celsius Holdings as brand Celsius showed sequential improvement in household penetration and buy rate suggesting better purchase frequency despite ongoing press
Wed Jun 18, 2025
PepsiCo vs. Celsius: Which Functional Beverage Player Has the Edge?. CELHs rapid growth and innovation challenge PEPs scale and stability as both target the booming functional beverage market.
Mon Jun 16, 2025
Celsius Stock Upgraded After 4-Month 95% Run Up. Celsius stock has rallied 95% over the past four months. Shares shifted higher Monday on an upgrade.The post Celsius Stock Upgraded After 4-Month 95% Run Up appeared first on Investor'.s Business Daily.
Mon Jun 16, 2025
Celsius Stock Is Upgraded. Why These Analysts Say the Energy Drink Maker Is a Buy..
Mon Jun 16, 2025
Celsius Stock Upgraded After 4-Month 95% Run Up.
Mon Jun 16, 2025
Celsius: Even Better After Buying Alani Still A Good Buy.
Mon Jun 16, 2025
Celsius Holdings rallies after TD Cowen points to Alani Nu upside.
Mon Jun 16, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
CELH Stock trends
CELH Stock performance
CELH Stock analysis
CELH investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings